In essence, our research suggested that EMP1 amplifies the tumorigenic attributes of PC both in vitro and in vivo, encompassing facets like cellular proliferation and metastatic potential orchestrated through the PI3K/AKT molecular conduit (Fig. S9). Here, EMP1 is linked to pachyonychia congenita.